Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre

Grieco, A.; Pompili, M.; Caminiti, G.; Miele, L.; Covino, M.; Alfei, B.; Rapaccini, G. L.; Gasbarrini, G.
March 2005
Gut;Mar2005, Vol. 54 Issue 3, p411
Academic Journal
Background: Several prognostic models have been developed to stage hepatocellular carcinoma (HCC) but there is no general consensus on which is the most reliable. We compared three prognostic indices (Okuda, CLIP, and BCLC scoring systems) in a large series of cirrhotic patients with HCC undergoing non- surgical treatment in terms of their ability to classify patients into different risk groups Methods: We retrospectively studied 268 Italian patients with HCC. A total of 146 patients were treated with oblation, 132 with percutaneous ethanol injection, and 14 with radiofrequency ablation; 103 underwent transcatheter arterial chemoembolisation and 19 had supportive care alone. Factors determining survival were analysed by univariate and multivariate analysis using the Kaplan-Meier method and Cox proportional hazard regression models. Okuda, CLIP, and BCLC scores evaluated before treatment were applied. Results: Median survival was 25.7 months. In a multivariate analysis, portal vein thrombosis, α fetoprotein, total bilirubin, and tumour size were significant predictors of survival. Okuda, CLIP, and BCLC scores were all able to predict survival (p<0.001). They identified two, four, and six risk groups, respectively, with a median survival ranging from 27 to 19 months for Okuda, 30 to 5 months for CLIP, and 43 to 7 months for BCLC. Conclusions: Both CLIP and BCLC scores were more effective than the Okuda score in stratifying patients into different risk groups with early-intermediate HCC. However, the BCLC scoring system gave a better prediction of prognosis in patients with disease diagnosis at a very early stage.


Related Articles

  • Anatomic wide hepatectomy for treatment of hepatocellular carcinoma. Ochiai, Toshiya; Sonoyama, Teruhisa; Kikuchi, Shojiro; Okayama, Tokunari; Konishi, Hiroo; Kitagawa, Masahiro; Tagi, Tomoyuki; Ueda, Yuji; Otsuji, Eigo // Journal of Cancer Research & Clinical Oncology;Aug2007, Vol. 133 Issue 8, p563 

    We aimed to clarify the prognostic impact of the anatomic extent of hepatic resection (Hr) related to the tumor hepatic involvement (H) on patients’ survival in the treatment of hepatocellular carcinoma (HCC). The 305 patients with HCC who had undergone hepatectomy were analyzed...

  • Determinants of Long-Term Outcome in Patients Undergoing Simultaneous Resection of Synchronous Colorectal Liver Metastases. Lin, Qi; Ye, Qinghai; Zhu, Dexiang; Wei, Ye; Ren, Li; Ye, Lechi; Feng, Qingyang; Xu, Pingping; Zheng, Peng; Lv, Minzhi; Fan, Jia; Xu, Jianmin // PLoS ONE;Aug2014, Vol. 9 Issue 8, p1 

    Background: It remains unclear which patients can benefit from simultaneous resection of synchronous colorectal liver metastases (SCRLMs). This study aimed to examine the prognostic value of patient- and tumor-related factors in predicting long-term outcomes of patients undergoing simultaneous...

  • The clinical relevance of the Fong and the Nordlinger scores in the era of effective neoadjuvant chemotherapy for colorectal liver metastasis. Schreckenbach, Teresa; Malkomes, Patrizia; Bechstein, Wolf; Woeste, Guido; Schnitzbauer, Andreas; Ulrich, Frank // Surgery Today;Dec2015, Vol. 45 Issue 12, p1527 

    Purpose: The clinical risk scores (CRSs) of Fong and Nordlinger are used to predict the outcome of patients with colorectal liver metastases (CRLMs). This study investigated whether CRSs could predict the overall survival of patients with CRLM treated with or without neoadjuvant chemotherapy...

  • Intraoperative Liver Ultrasound Still Affects Surgical Strategy for Patients with Colorectal Metastases in the Modern Era. Ferrero, Alessandro; Langella, Serena; Giuliante, Felice; Viganò, Luca; Vellone, Maria; Zimmitti, Giuseppe; Ardito, Francesco; Nuzzo, Gennaro; Capussotti, Lorenzo // World Journal of Surgery;Nov2013, Vol. 37 Issue 11, p2655 

    Background: The present study was designed to evaluate the role of intraoperative ultrasound (IOUS) in intrahepatic staging and the impact on surgical strategy for patients with colorectal liver metastases (CRLM). Methods: The study included 515 patients who had undergone liver resection for...

  • Survival of patients with hepatocellular carcinoma in the San Joaquin Valley: a comparison with California Cancer Registry data. Atla, Pradeep R.; Sheikh, Muhammad Y.; Mascarenhas, Ranjan; Choundhury, Jayanta; Mills, Paul // Annals of Gastroenterology;Apr2012, Vol. 25 Issue 2, p138 

    Background Variation in the survival of patients with hepatocellular carcinoma (HCC) is related to racial differences, socioeconomic disparities and treatment options among different populations. Methods A retrospective review of the data from medical records of patients diagnosed with HCC were...

  • Transcutaneous Treatments of Hepatocellular Carcinoma in Patients with Cirrhosis: Present Status and Future Developments. Beaugrand, Michel; Seror, Olivier // Current Pharmaceutical Design;Nov2007, Vol. 13 Issue 32, p3274 

    Hepatocellular carcinoma is in 90% of cases associated with cirrhosis and to preserve liver function while destroying the tumor is a main issue in these patients justifying the development of local percutaneous ablative therapies. Alcoholization and radiofrequency ablation are the most widely...

  • Assessment of ISGLS Definition of Posthepatectomy Liver Failure and Its Effect on Outcome in Patients with Hepatocellular Carcinoma. Fukushima, Kenji; Fukumoto, Takumi; Kuramitsu, Kaori; Kido, Masahiro; Takebe, Atsushi; Tanaka, Motofumi; Itoh, Tomoo; Ku, Yonson // Journal of Gastrointestinal Surgery;Apr2014, Vol. 18 Issue 4, p729 

    Background: Posthepatectomy liver failure (PHLF) is a major complication after hepatectomy. As there was no standardized definition, the International Study Group of Liver Surgery (ISGLS) defined PHLF as increased international normalized ratio and hyperbilirubinemia on or after postoperative...

  • Sorafenib.  // Reactions Weekly;Apr2015, Vol. 1547 Issue 1, p244 

    The article presents a case study of a 76-year-old man who developed subcorneal pustural dermatosis (SCPD) and hand-foot skin reaction (HFSR) during treatment with sorafenib for hepatocellular carcinoma.

  • Sorafenib a boon for patients awaiting liver transplants.  // PharmacoEconomics & Outcomes News;3/6/2010, Issue 598, p5 

    The article discusses research on the cost effectiveness of sorafenib neoadjuvant therapy in patients with hepatocellular cancer.


Read the Article


Sign out of this library

Other Topics